Skip to main content
. 2007 Feb 13;96(5):725–731. doi: 10.1038/sj.bjc.6603607

Table 3. Platinum–DNA adduct levels determined in patients following carboplatin administration on days 1 and 5 of treatment in four patients on the MMT 98 protocol.

Patient Study day Carboplatin dose (mg) Carboplatin AUC (mg ml−1 .min) Pt-DNA adducts (nmol g−1DNA)
1 1 522 5.2 2.28
  5 203 1.9 6.99
2 1 380 2.5 0.24
  5 860 7.8 2.21
3 1 732 5.1 0.59
  5 534 5.8 4.06
4 1 418 3.8 0.57
  5 418 4.2 3.21